Nanotechnology Regulation Limited By FDA Budget Constraints – Report

FDA's budget constraints and gaps in its legal authority hinder its ability to understand and manage nanotechnology's potential risks, according to Michael Taylor, a professor at the University of Maryland School of Medicine who formerly served as deputy commissioner for policy at FDA